Budget Amount *help |
¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2014: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2013: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2012: ¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000)
|
Outline of Final Research Achievements |
The norepinephrine transporter (NET) is one of the key drug targets for major depression disorder (MDD). We measured NET availability (BPND) values in 13 medication-free patients with MDD and 13 age- and sex-matched healthy controls using positron emission tomography (PET) with (S,S)-[18F]FMeNER-D2. Compared to healthy controls, patients showed a significantly higher NET BPND in the thalamus, in particular, in the sub-region connected to the prefrontal cortex. This study provides evidence of impaired cortical-thalamic connections innervated by norepinephrine systems in MDD.
|